List of synthetic cannabinoids patents

Patent 7209075 was granted and assigned to Pfizer on April, 2007 by the United States Patent and Trademark Office.

Patent 7030242 was granted and assigned to Pfizer on April, 2006 by the United States Patent and Trademark Office.

Patent 7232680 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.

Patent 7132106 was granted and assigned to Pfizer on November, 2006 by the United States Patent and Trademark Office.

Patent 11400052 was granted and assigned to Jazz Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

Patent 7405226 was granted and assigned to Pfizer on July, 2008 by the United States Patent and Trademark Office.

Patent 7118885 was granted and assigned to Pfizer on October, 2006 by the United States Patent and Trademark Office.

Patent 9775379 was granted and assigned to Syqe on October, 2017 by the United States Patent and Trademark Office.

Patent 11311480 was granted and assigned to Syqe on April, 2022 by the United States Patent and Trademark Office.

Patent 7387623 was granted and assigned to Pfizer on June, 2008 by the United States Patent and Trademark Office.

Patent 7231074 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.

Patent 11410779 was granted and assigned to Jazz Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

Patent 7101869 was granted and assigned to Pfizer on September, 2006 by the United States Patent and Trademark Office.

Patent 11291781 was granted and assigned to Syqe on April, 2022 by the United States Patent and Trademark Office.

Patent 7301023 was granted and assigned to Pfizer on November, 2007 by the United States Patent and Trademark Office.

Patent 7229615 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.

Patent 11298477 was granted and assigned to Syqe on April, 2022 by the United States Patent and Trademark Office.

Patent 9839241 was granted and assigned to Syqe on December, 2017 by the United States Patent and Trademark Office.

Patent 11406728 was granted and assigned to Vivera Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.

Patent RE49361 was granted and assigned to Jazz Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.

Patent 7336227 was granted and assigned to Pfizer on February, 2008 by the United States Patent and Trademark Office.

Patent 7113126 was granted and assigned to Pfizer on September, 2006 by the United States Patent and Trademark Office.

Patent 11364215 was granted and assigned to Jazz Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.